A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity

Volume: 4, Issue: 1
Published: Sep 20, 2019
Abstract
Growing evidence suggests that inflammation is a significant contributor to different cardiovascular diseases (CVDs). Mendelian randomization (MR) was performed to assess the causal inference between plasma soluble IL6 receptor (sIL6R), a negative regulator of IL6 signaling, and different cardiovascular and immune-related disorders. Cis-MR with multiple instrumental variables showed an inverse association of sIL6R with rheumatoid arthritis,...
Paper Details
Title
A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity
Published Date
Sep 20, 2019
Volume
4
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.